Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance

BACKGROUND: Familial partial lipodystrophy type 3 (FPLD3) is a very rare autosomal dominant genetic disorder which is caused by mutations in the peroxisome proliferator activated receptor gamma (PPARG) gene. It is characterized by a partial loss of adipose tissue leading to subnormal leptin secretio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Lambadiari, Vaia, Kountouri, Aikaterini, Maratou, Eirini, Liatis, Stavros, Dimitriadis, George D., Karpe, Fredrik
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217860/
https://ncbi.nlm.nih.gov/pubmed/34168618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.684182
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars